
Gonal-F300
Injection
Medicine overview
Indications of Gonal-F 300
Theropeutic Class
Pharmacology
Follitropin alfa is a human FSH preparation of recombinant DNA origin.
It stimulates ovarian follicular growth in women who do not have primary ovarian failure and stimulates spermatogenesis in men with hypogonadotrophic hypogonadism.
Dosage & Administration of Gonal-F 300
| Condition | Dosage | Notes |
|---|---|---|
| Female infertility | Dose should be individualised | |
| Recommended initial | 75 IU/day; may increase by up to 37.5 IU after 14 days; further increases of the same magnitude may be made every 7 days, if needed | |
| Max | 300 IU/day | If response is appropriate, administer hCG 1 day after the last dose |
| Assisted reproductive technologies Initial | 150-225 IU/day for at least 4 days, to be started on day 2 or 3 of cycle, until follicular development is adequate | Adjust dose based on ovarian response |
| Usual max | 450 IU/day | Once follicular development is adequate, administer hCG to induce final follicular maturation. Withhold hCG if ovaries are abnormally enlarged. Spermatogenesis induction 150 IU 3 times/week with continued chorionic gonadotrophin for at least 4 mth |
| Max | 300 IU 3 times/week |
Dosage of Gonal-F 300
| Condition | Dosage | Notes |
|---|---|---|
| Female infertility | Dose should be individualised | |
| Recommended initial | 75 IU/day; may increase by up to 37.5 IU after 14 days; further increases of the same magnitude may be made every 7 days, if needed | |
| Max | 300 IU/day | If response is appropriate, administer hCG 1 day after the last dose |
| Assisted reproductive technologies Initial | 150-225 IU/day for at least 4 days, to be started on day 2 or 3 of cycle, until follicular development is adequate | Adjust dose based on ovarian response |
| Usual max | 450 IU/day | Once follicular development is adequate, administer hCG to induce final follicular maturation. Withhold hCG if ovaries are abnormally enlarged. Spermatogenesis induction 150 IU 3 times/week with continued chorionic gonadotrophin for at least 4 mth |
| Max | 300 IU 3 times/week |
Interaction of Gonal-F 300
Contraindications
Side Effects of Gonal-F 300
Pregnancy & Lactation
Precautions & Warnings
Storage Conditions
Drug Classes
Mode Of Action
Pregnancy
Frequently Asked Questions
What is Gonal-F 300 used for?
Women: Follitropin alfa is indicated for the induction of ovulation and pregnancy in the anovulatory infertile patient in whom the cause of infertility is functional and not due to primary ovarian failure. Follitropin alfa is also indicated ... Read moreWomen: Follitropin alfa is indicated for the induction of ovulation and pregnancy in the anovulatory infertile patient in whom the cause of infert…
What is the dosage of Gonal-F 300?
Female infertility: Dose should be individualised. Recommended initial: 75 IU/day; may increase by up to 37.5 IU after 14 days; further increases of the same magnitude may be made every 7 days, if needed. Max: 300 IU/day. If response is appropriate, administer hCG 1 day after the last dose. Assisted reproductive technologies Initial: 150-225 IU/day for at least 4 days, to be started on day 2 or 3 …
What are the side effects of Gonal-F 300?
Ovarian cysts, mild to severe Inj site reactions, headache, mild to moderate ovarian hyperstimulation syndrome (OHSS), abdominal pain, GI disturbances. Rarely, severe OHSS, ovarian torsion, thromboembolism, mild systemic allergic reactions.
Who should not take Gonal-F 300?
Hypersensitivity. Abnormal genital bleeding of undetermined origin, sex hormone sensitive malignancies of the reproductive tract and accessory organs, an organic intracranial lesion e.g. pituitary tumor, ovarian cysts or enlargement of undetermined origin, high levels of FSH indicating primary gonadal failure, uncontrolled thyroid or adrenal dysfunction, pregnancy, lactation.
What precautions should be taken with Gonal-F 300?
May result in multiple births. Ovarian hyperstimulation syndrome, serious pulmonary conditions and thromboembolic events may occur. Evaluate patients for hypothyroidism, adrenocortical deficiency, hyperprolactinaemia, pituitary and hypothalamic tumors before starting therapy.
Is Gonal-F 300 safe during pregnancy and breastfeeding?
Pregnancy category X. Studies in animals or human beings have demonstrated foetal abnormalities or there is evidence of foetal risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant.
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.